Cargando…

LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation

High-dose chemotherapy (HDT) followed by autologous hematopoietic stem cell transplantation (ASCT) is widely used in patients with malignant lymphomas. In Europe over 8,000 ASCTs for lymphoma were performed out of a total of 40,000 transplants according to the European Bone Marrow Transplant (EBMT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colita, Andrei, Colita, Anca, Bumbea, Horia, Croitoru, Adina, Orban, Carmen, Lipan, Lavinia Eugenia, Craciun, Oana-Gabriela, Soare, Dan, Ghimici, Cecilia, Manolache, Raluca, Gelatu, Ionel, Vladareanu, Ana-Maria, Pasca, Sergiu, Teodorescu, Patric, Dima, Delia, Lupu, Anca, Coriu, Daniel, Tomuleasa, Ciprian, Tanase, Alina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746965/ https://www.ncbi.nlm.nih.gov/pubmed/31552193 http://dx.doi.org/10.3389/fonc.2019.00892

Ejemplares similares

Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma—Romanian Experience
por: Tanase, Alina D., et al.
Publicado: (2020)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies
por: Cenariu, Diana, et al.
Publicado: (2022)

Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS
por: Sharma, Atul, et al.
Publicado: (2013)

Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma
por: Deak-Mihaly, Dalma, et al.
Publicado: (2021)

Rare case of disseminated fusariosis in a young patient with graft vs. host disease following an allogeneic transplant
por: Tanase, Alina, et al.
Publicado: (2016)

P1367: COMPARISON CONDITIONING REGIMENS (BEEAC,LEAM,CLV) BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION FOR TREATMENT OF PRIMARY-REFRACTORY AND RELAPSED FORMS HODGKIN’S LYMPHOMA
por: Samoylova, A., et al.
Publicado: (2022)

Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation
por: Cima, Luminita Nicoleta, et al.
Publicado: (2017)

Induced Coma, Death, and Organ Transplantation: A Physiologic, Genetic, and Theological Perspective
por: Coliță, Cezar-Ivan, et al.
Publicado: (2023)

Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond
por: Balduzzi, Adriana, et al.
Publicado: (2022)

Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia
por: Marcu, Andra, et al.
Publicado: (2020)

Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study
por: Schmidt, Madalina-Petronela, et al.
Publicado: (2021)

Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
por: Cima, Luminita Nicoleta, et al.
Publicado: (2018)

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases
por: Radu, Letitia-Elena, et al.
Publicado: (2020)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia
por: Deak, Dalma, et al.
Publicado: (2019)

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
por: Constantinescu, Catalin, et al.
Publicado: (2020)

The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
por: Serbanica, Andreea Nicoleta, et al.
Publicado: (2023)

Prenatal molecular diagnosis of β-thalassemia: report on the first two cases in Romania
por: Talmaci, R, et al.
Publicado: (2008)

Real-World Evidence: The Low Validity of Temperature Screening for COVID-19 Triage
por: Pană, Bogdan C., et al.
Publicado: (2021)

Controversial Flow Cytometry Monitoring of a Relapse Case of Pediatric T Cell Acute Lymphoblastic Leukemia: A Case Report
por: Popa, Delia Codruţa, et al.
Publicado: (2022)

The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia
por: Crisan, AM, et al.
Publicado: (2015)

DEBATE UPFRONT vs DELAYED TRANSPLANT
por: Gay, F.
Publicado: (2023)

The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression – an overlapping myeloproliferative disorder or two distinct diseases? - case report
por: Ursuleac, I, et al.
Publicado: (2013)

Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
por: Andronesi, Andreea G., et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT
por: Neven, Benedicte, et al.
Publicado: (2020)

Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician
por: Constantinescu, Catalin, et al.
Publicado: (2019)

Primary Liver Transplantation vs. Transplant after Kasai Portoenterostomy for Infants with Biliary Atresia
por: Lemoine, Caroline P., et al.
Publicado: (2022)

The simultaneous occurrence of multiple myeloma and JAK2 positive myeloproliferative neoplasms - Report on two cases
por: Badelita, S, et al.
Publicado: (2015)

Screening for Low Energy Availability in Male Athletes: Attempted Validation of LEAM-Q
por: Lundy, Bronwen, et al.
Publicado: (2022)

Balancing Outcome vs. Urgency in Modern Liver Transplantation
por: Dancs, Peter T., et al.
Publicado: (2022)

Allograft nephrectomy vs. no nephrectomy for failed renal transplants
por: McDonald, Michelle
Publicado: (2023)

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
por: Bailén, Rebeca, et al.
Publicado: (2023)

Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution
por: Turbatu, Andrei, et al.
Publicado: (2023)

LFU tests in $b \to clv$ decays at LHCb
por: Mohammed, Rizwaan Adeeb
Publicado: (2023)

Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers
por: Cascino, Thomas M., et al.
Publicado: (2022)

Unperturbed vs. post-transplantation hematopoiesis: both in vivo but different
por: Busch, Katrin, et al.
Publicado: (2016)

Graft-vs-Host Disease Colitis After Lung Transplant
por: Kanthasamy, Kavin, et al.
Publicado: (2019)

The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
por: Patel, Rima, et al.
Publicado: (2020)

Challenges of paediatric palliative care in Romania: a focus groups study
por: Pacurari, Nadia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_284o4qt7u3fu7grislb5rituek